Bernard Gonik
Maternal & Fetal Medicine Detroit, MI Medical Doctor
NPI 1164469680 CMS profile 324598
Sinai Grace Hospital-Atenatal Diagnostic Unit, 6071 W Outer Dr, Detroit, MI 48235
General payments
$140,886
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$304,478
Through program year 2025, Bernard Gonik of Detroit, MI is reported in the CMS Open Payments database as having received $140,886 across 78 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $304,478 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 99th percentile of Maternal & Fetal Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $18,048 | 22 | |
| 2024 | General | $49,510 | 17 | |
| 2023 | General | $28,021 | 11 | |
| 2022 | General | $3,510 | 1 | |
| 2021 | General | $22,151 | 7 | |
| 2020 | General | $4,550 | 2 | |
| 2019 | General | $15,096 | 18 |
Beside peers
- Bernard Gonik
- Maternal & Fetal Medicine median
- Middle half of Maternal & Fetal Medicine
- National median
In program year 2025, general payments to Bernard Gonik were reported at $18,048. Among 891 Maternal & Fetal Medicine profiles paid that year, the median was $56 and the middle half received between $25 and $146.
Show as a table
| Year | Bernard Gonik | Maternal & Fetal Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $15,096 | $70 | $23–$148 | $163 |
| 2020 | $4,550 | $51 | $18–$141 | $114 |
| 2021 | $22,151 | $43 | $20–$137 | $132 |
| 2022 | $3,510 | $48 | $22–$145 | $149 |
| 2023 | $28,021 | $53 | $24–$150 | $160 |
| 2024 | $49,510 | $68 | $25–$159 | $164 |
| 2025 | $18,048 | $56 | $25–$146 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
78 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Maternal & Fetal Medicine in Michigan
Sara Garmel
Maternal & Fetal Medicine · Dearborn, MI
Eryn Hart
Maternal & Fetal Medicine · Grand Rapids, MI
Alexa Paulina Marquez
Maternal & Fetal Medicine · Grand Rapids, MI
Robert Welch
Maternal & Fetal Medicine · Flint, MI
Lami Yeo
Maternal & Fetal Medicine · Detroit, MI
Emily Bunce
Maternal & Fetal Medicine · Kalamazoo, MI
Related records
Maternal & Fetal Medicine in Michigan
Practitioners in the same specialty and state, ranked by reported value.
All Maternal & Fetal Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Michigan
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.